Zoetis Q3 Earnings Beat, Companion Animal Segment Growth Gives Confidence Into 2025: Analyst
On Monday, Zoetis Inc’s (NYSE:ZTS) third-quarter 2024 adjusted EPS increased 16% year over year to $1.58, beating the consensus of $1.46. The animal health firm reported sales of $2.39 billion, up 11%,
Zoetis Beats Q3 Earnings Expectations
Zoetis saw notable growth in both companion animal and livestock segments.
Q3 2024 Zoetis Inc Earnings Call
Linda Rhodes; Independent Director; Zoetis Inc Wetteny Joseph; Chief Financial Officer, Executive Vice President; Zoetis Inc Brandon Vazquez; Analyst; William Blair & Company L.L.C. David Westenberg; Analyst; Piper Sandler & Co. Navann Ty Dietschi; Analyst; BNP Paribas Exane
Zoetis: Q3 Earnings Snapshot
The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $1.46 per share. The animal health company posted revenue of $2.39 billion in the period, which also topped Street forecasts.
Zoetis (ZTS) Q3 2024 Earnings Call Transcript
Welcome to the third quarter 2024 financial results conference call and webcast for Zoetis. Hosting the call today is Steve Frank, vice president of in
New York Times: Q3 Earnings Snapshot
The New York Times Co. (NYT) on Monday reported net income of $64.1 million in its third quarter. The New York-based company said it had profit of 39 cents per share. Earnings, adjusted for one-time gains and costs,
Sensata: Q3 Earnings Snapshot
The average estimate of seven analysts surveyed by Zacks Investment Research was also for earnings of 86 cents per share. The maker of sensing, electrical protection, control and power management products posted revenue of $982.
TriMas: Q3 Earnings Snapshot
TriMas expects full-year earnings in the range of $1.70 to $1.90 per share. This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on
Yahoo Finance3h
Zoetis Inc (ZTS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Divestitures
Full Year 2024 Adjusted Diluted EPS Guidance: $5.86 to $5.92. Zoetis Inc (NYSE:ZTS) reported a 14% operational revenue growth and a 15% increase in adjusted net income, showcasing strong financial ...
Zoetis reports Q3 adjusted EPS $1.58, consensus $1.45
Reports Q3 revenue $2.39B, consensus $2.29B. “Building on the strong momentum from the first half of the year, we are proud to have ...
Nasdaq5d
Gear Up for Zoetis (ZTS) Q3 Earnings: Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Zoetis (ZTS) will report quarterly earnings of $1.46 per share in its upcoming release, pointing to a year-over-year increase of 7.4%. It is anticipated that ...
Zoetis raises annual forecasts on strong demand for pet treatments
Zoetis raised its annual profit and revenue forecasts on Monday on strong demand for its medicines and vaccines for animals.
Barclays Sticks to Their Buy Rating for Zoetis (ZTS)
Barclays analyst Balaji Prasad maintained a Buy rating on Zoetis (ZTS – Research Report) today and set a price target of $242.00. The ...
Investing on MSN21h
Zoetis lifts full-year guidance amid strength at companion animal unit
Shares in Zoetis (NYSE: ZTS) edged higher in premarket US trading on Monday after the drugmaker reported better-than-anticipated third-quarter earnings and revenu ...
Zoetis Inc. (ZTS) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Conference Call November 4, 2024 8:30 AM ETCompany ParticipantsSteve Frank - VP of IRKristin Peck - ...